Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

MLA

Phillips, Andrew N., et al. “Cost-Effectiveness of Public-Health Policy Options in the Presence of Pretreatment NNRTI Drug Resistance in Sub-Saharan Africa: A Modelling Study.” The Lancet HIV, vol. 5, no. 3, Mar. 2018, pp. e146–54. EBSCOhost, https://doi.org/10.1016/S2352-3018(17)30190-X.

APA

Phillips, A. N., Cambiano, V., Nakagawa, F., Revill, P., Jordan, M. R., Hallett, T. B., Doherty, M., De Luca, A., Lundgren, J. D., Mhangara, M., Apollo, T., Mellors, J., Nichols, B., Parikh, U., Pillay, D., Rinke de Wit, T., Sigaloff, K., Havlir, D., Kuritzkes, D. R., … Bertagnolio, S. (2018). Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study. The Lancet HIV, 5(3), e146–e154. https://doi.org/10.1016/S2352-3018(17)30190-X

Chicago

Phillips, Andrew N, Valentina Cambiano, Fumiyo Nakagawa, Paul Revill, Michael R Jordan, Timothy B Hallett, Meg Doherty, et al. 2018. “Cost-Effectiveness of Public-Health Policy Options in the Presence of Pretreatment NNRTI Drug Resistance in Sub-Saharan Africa: A Modelling Study.” The Lancet HIV 5 (3): e146–54. doi:10.1016/S2352-3018(17)30190-X.